My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Fri 27 Nov 2009 | 1:58 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Generex Biotechnology Corp
Generex Biotechnology Corp (GNBT.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
GNBT
on other exchanges
As of 25 Nov 2009
0.49
USD
Price Change
-0.01
Percent Change
-2.20%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Jul 2009
Barratt, John
--
--
--
--
Bernstein, Gerald
200,000
--
29,500
229,500
Fletcher, Mark
315,000
--
--
333,875
Gluskin, Anna
525,000
--
33,210
595,960
Masterson, Nola
--
--
--
--
McGee, Brian
--
--
--
--
Perri, Rose
420,000
--
48,574
501,605
Find out more about GNBT.O
Insider Trading